| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | paclitaxel | CCLE | pan-cancer | AAC | 0.19 | 9e-05 |
| mRNA | Topotecan | CCLE | pan-cancer | AAC | 0.14 | 0.002 |
| mRNA | PHA-665752 | CCLE | pan-cancer | AAC | -0.12 | 0.01 |
| mRNA | 17-AAG | CCLE | pan-cancer | AAC | 0.099 | 0.04 |
| mRNA | PLX4720 | CCLE | pan-cancer | AAC | -0.087 | 0.06 |
| mRNA | Irinotecan | CCLE | pan-cancer | AAC | 0.1 | 0.08 |
| mRNA | AEW541 | CCLE | pan-cancer | AAC | -0.08 | 0.1 |
| mRNA | Nilotinib | CCLE | pan-cancer | AAC | -0.087 | 0.1 |
| mRNA | Nutlin-3 | CCLE | pan-cancer | AAC | -0.077 | 0.1 |
| mRNA | L-685458 | CCLE | pan-cancer | AAC | -0.063 | 0.2 |